Oct-6 transcription factor

International Review of Neurobiology

Volumn 59, Issue , 2004, Pages 471-489

  Ilia, Maria ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; NERVE PROTEIN; OCTAMER TRANSCRIPTION FACTOR 6; POU3F1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NERVOUS SYSTEM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; SCHIZOPHRENIA;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; NERVE TISSUE PROTEINS; NERVOUS SYSTEM; OCTAMER TRANSCRIPTION FACTOR-6; PROTEIN STRUCTURE, TERTIARY; SCHIZOPHRENIA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 2342477178     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(04)59018-9     Document Type: Article

References (76)

1. Agarwal, V. R., and Sato, S. M. (1991). XLPOU 1 and XLPOU 2, two novel POU domain genes expressed in the dorsoanterior region of Xenopus embryos. Dev. Biol. 147, 363-373.
2. Akbarian, S., Bunney, W. E., Jr., Potkin, S. G., Wigal, S. B., Hagman, J. O., Sandman, C. A., and Jones, E. G. (1993). Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psych. 50, 169-177.
3. Alvarez-Bolado, G., Rosenfeld, M. G., and Swanson, L. W. (1994). Model of forebrain regionalization based on spatiotemporal patterns of POU-III homeobox gene expression, birthdates, and morphological features. J. Comp. Neurol. 355, 237-295.
4. Arnold, S. E., and Trojanowski, J. Q. (1996). Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. 92, 217-231.
5. Baeuerle, P., and Baltimore, D. (2002). NF-Kappa B: Ten years after. Cell 87, 13-20.
6. Beasley, C., Cotter, D., Khan, N., Pollard, C., Sheppard, P., Varndell, I., Lovestone, S., Anderton, B., and Everall, I. (2001). Glycogen sythase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci. Lett. 302, 117-120.
7. Bermingham, J. R., Jr., Scherer, S. S., O'Connell, S., Arroyo, E., Kalla, K. A., Powell, F. L., and Rosenfeld, M. G. (1996). Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev. 10, 1751-1762.
8. Bermingham, J. R., Jr., Shumas, S., Whisenhunt, T., Sirkowski, E. E., O'Connell, S., Scherer, S. S., and Rosenfeld, M. G. (2002). Identification of genes that are downregulated in the absence of the POU domain transcription factor pou3f1 (Oct-6, Tst-1, SCIP) in sciatic nerve. J. Neurosci. 22, 10217-10231.
9. Blanchard, A. D., Sinanan, A., Parmantier, E., Zwart, R., Broos, L., Meijer, D., Meier, C., Jessen, K. R., and Mirsky, R. (1996). Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: Comparison with Oct-1, Krox-20, and Pax-3. J. Neurosci. Res. 46, 630-640.
10. Burglin, T. R., Finney, M., Coulson, A., and Ruvkun, G. (1989). Caenorhabditis elegans has scores of homoeobox-containing genes. Nature 341, 239-243.
11. Chan, C. H., Godinho, L. N., Thomaidou, D., Tan, S. S., Gulisano, M., and Parnavelas, J. G. (2001). Emx1 is a marker for pyramidal neurons of the cerebral cortex. Cereb. Cortex 11, 1191-1198.
12. Collarini, E. J., Kuhn, R., Marshall, C. J., Monuki, E. S., Lemke, G., and Richardson, W. D. (1992). Down-regulation of the POU transcription factor SCIP is an early event in oligodendrocyte differentiation in vitro. Development 116, 193-200.
13. Cooper, S. J. (1992). Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Br. J. Psych. 161, 394-396.
14. Cotter, D., Wilson, S., Roberts, E., Kerwin, R., and Everall, I. P. (2000). Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr. Res. 41, 313-323.
15. Crow, T. J., Ball, J., Bloom, S. R., Brown, R., Bruton, C. J., Colter, N., Frith, C. D., Johnstone, E. C., Owens, D. G., and Roberts, G. W. (1989). Schizophrenia as an anomaly of development of cerebral asymmetry: A postmortem study and a proposal concerning the genetic basis of the disease. Arch. Gen. Psychiat. 46, 1145-1150.
16. Deneris, E. S., Francis, N., McDonough, J., Fyodorov, D., Miller, T., and Yang, X. (2000). Transcriptional control of the neuronal nicotinic acetylcholine receptor gene cluster by the beta43′ enhancer, Sp1, SCIP and ETS transcription factors. Eur. J. Pharmacol. 393, 69-74.
17. Frantz, G. D., Bohner, A. P., Akers, R. M., and McConnell, S. K. (1994). Regulation of the POU domain gene Oct-6 during cerebral cortical development. J. Neurosci. 14, 472-485.
18. Garcia-Segura, L. M., Azcoitia, I., and DonCarlos, L. L. (2001). Neuroprotection by estradiol. Prog. Neurobiol. 63, 29-60.
19. Harrison, P. J. (1999). The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain 122, 593-624.
20. He, X., and Rosenfeld, M. G. (1991). Mechanisms of complex transcriptional regulation: Implications for brain development. Neuron 7, 183-196.
21. He, X., Treacy, M. N., Simmons, D. M., Ingraham, H. A., Swanson, L. W., and Rosenfeld, M. G. (1989). Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340, 35-42.
22. Herr, W., and Cleary, M. A. (1995). The POU domain: Versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9, 1679-1693.
23. Herr, W., Sturm, R. A., Clerc, R. G., Corcoran, L. M., Baltimore, D., Sharp, P. A., Ingraham, H. A., Rosenfeld, M. G., Finney, M., Ruvkun, G., et al. (1988). The POU domain: A large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2, 1513-1516.
24. Hsieh, C. L., Sturm, R., Herr, W., and Francke, U. (1990). The gene for the ubiquitous octamer-binding protein Oct-1 is on human chromosome 1, region cen-q32, and near Ly-22 and Ltw-4 on mouse chromosome 1. Genomics 6, 666-672.
25. Ilia, M., Bazigou, E., and Price, J. (2003). Expression of the POU domain transcription factor, Oct-6, is attenuated in the adult mouse telencephalon, but increased by neurotoxic damage. Exp. Neurol 181, 159-169.
26. Ilia, M., Beasley, C., Cotter, D., Kerwin, R., Everall, I., and Price, J. (2002). Expression of Oct-6, a POU III domain transcription factor, in schizophrenia. Am. J. Psych. 159, 1174-1182.
27. Imai, S., Nishibayashi, S., Takao, K., Tomifuji, M., Fujino, T., Hasegawa, M., and Takano, T. (1997). Dissociation of Oct-1 from the nuclear peripheral structure induces the cellular aging-associated collagenase gene expression. Mol. Biol. Cell 8, 2407-2419.
28. Jaegle, M., and Meijer, D. (1998). Role of Oct-6 in Schwann cell differentiation. Microsc. Res. Tech. 41, 372-378.
29. Jaegle, M., Mandemakers, W., Broos, L., Zwart, R., Karis, A., Visser, P., Grosveld, F., and Meijer, D. (1996). The POU factor Oct-6 and Schwann cell differentiation. Science 273, 507-510.
30. Jensen, N. A., Pedersen, K. M., Celis, J. E., and West, M. J. (1998). Neurological disturbances, premature lethality, and central myelination deficiency in transgenic mice overexpressing the homeo domain transcription factor Oct-6. J. Clin. Invest. 101, 1292-1299.
31. Jessen, K. R., and Mirsky, R. (1998). Origin and early development of Schwann cells. Microsc. Res. Tech. 41, 393-402.
32. Johansen, T., Moens, U., Holm, T., Fjose, A., and Krauss, S. (1993). Zebrafish pou[c]: A divergent POU family gene ubiquitously expressed during embryogenesis. Nucleic Acids Res. 21, 475-483.
33. Jones, P., Rogers, B., Murray, R., and Marmot, M. (1994). Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344, 1398-1402.
34. Jones-Brando, L. V., Buthod, J. L., Holland, L. E., Yolken, R. H., and Torrey, E. F. (1997). Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1. Schizophr. Res. 25, 63-70.
35. Lewis, S. W., and Murray, R. M. (1987). Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J. Psych. Res. 21, 413-421.
36. Lillehoj, E. P., Ford, G. M., Bachmann, S., Schroder, J., Torrey, E. F., and Yolken, R. H. (2000). Serum antibodies reactive with non-human primate retroviruses identified in acute onset schizophrenia. J. Virol. 6, 492-497.
37. Liu, Q., Melnikova, I. N., Hu, M., and Gardner, P. D. (1999). Cell type-specific activation of neuronal nicotinic acetylcholine receptor subunit genes by Sox10. J. Neurosci. 19, 9747-9755.
38. Mallamaci, A., Iannone, R., Briata, P., Pintonello, L., Mercurio, S., Boncinelli, E., and Corte, G. (1998). EMX2 protein in the developing mouse brain and olfactory area. Mech. Dev. 77, 165-172.
39. Mallamaci, A., Mercurio, S., Muzio, L., Cecchi, C., Pardini, C. L., Gruss, P., and Boncinelli, E. (2000). The lack of Emx2 causes impairment of Reelin signaling and defects of neuronal migration in the developing cerebral cortex. J. Neurosci. 20, 1109-1118.
40. Mandemakers, W., Zwart, R., Jaegle, M., Walbeehm, E., Visser, P., Grosveld, F., and Meijer, D. A. (2000). Distal Schwann cell-specific enhancer mediates axonal regulation of the Oct-6 transcription factor during peripheral nerve development and regeneration. EMBO J. 12, 2992-3003.
41. Mandemakers, W., Zwart, R., Kraay, R., Grosveld, G., Jaegle, A. G., Broos, L., and Meijer, D. (1999). Transcriptional regulation of the POU gene Oct-6 in Schwann cells. Adv. Exp. Med. Biol. 468, 13-22.
42. McCarley, R. W., Niznikiewicz, M. A., Salisbury, D. F., Nestor, P. G., O'Donnell, B. F., Hirayasu, Y., Grunze, H., Greene, R. W., and Shenton, M. E. (1999). Cognitive dysfunction in schizophrenia: Unifying basic research and clinical aspects. Eur. Arch. Psychiat. Clin. Neurosci. 4, 69-82.
43. McNeill, T. F. (1995). Perinatal risk factors and schizophrenia: Selective review and methodological concerns. Epidemiol. Rev. 17, 107-112.
44. Meijer, D., Graus, A., Kraay, R., Langeveld, A., Mulder, M. P., and Grosveld, G. (1990). The octamer binding factor Oct6: cDNA cloning and expression in early embryonic cells. Nucleic Acids Res. 18, 7357-7365.
45. Mirsky, R., and Jessen, K. R. (1996). Schwann cell development, differentiation and myelination. Curr. Opin. Neurobiol. 1, 89-96.
46. Monuki, E. S., Kuhn, R., and Lemke, G. (1993). Cell-specific action and mutable structure of a transcription factor effector domain. Proc. Natl. Acad. Sci. USA 90, 9978-9982.
47. Monuki, E. S., Kuhn, R., Weinmaster, G., Trapp, B. D., and Lemke, G. (1990). Expression and activity of the POU transcription factor Oct-6. Science 249, 1300-1303.
48. Monuki, E. S., Weinmaster, G., Kuhn, R., and Lemke, G. (1989). SCIP: A glial POU domain gene regulated by cyclic AMP. Neuron 3, 783-793.
49. Nakagawa, Y., Johnson, J. E., and O'Leary, D. D. (1999). Graded and areal expression patterns of regulatory genes and cadherins in embryonic neocortex independent of thalamocortical input. J. Neurosci. 19, 10877-10885.
50. Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., Yung, A. R., Bullmore, E. T., Brewer, W., Soulsby, B., Desmond, P., and McGuire, P. K. (2003). Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison. Lancet 361, 281-288.
51. Renner, K., Leger, H., and Wegner, M. (1994). The POU domain protein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proc. Natl. Acad. Sci. USA 91, 6433-6437.
52. Rohdewohld, H., and Gruss, P. (1992). The gene for the POU domain transcription factor Oct-6 maps to the distal end of mouse chromosome 4. Mamm. Genome 3, 119-121.
53. Ryan, A. K., and Rosenfeld, M. G. (1997). POU domain family values: Flexibility, partnerships, and developmental codes. Genes Dev. 11, 1207-1225.
54. Scherer, S. S., Wang, D. Y., Kuhn, R., Lemke, G., Wrabetz, L., and Kamholz, J. (1994). Axons regulate Schwann cell expression of the POU transcription factor SCIP. J. Neurosci. 14, 1930-1942.
55. Scholer, H. R., Dressler, G. R., Balling, R., Rohdewohld, H., and Gruss, P. (1990). Oct-4: A germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 9, 2185-2195.
56. Shelton, R. C., Karson, C. N., Doran, A. R., Pickar, D., Bigelow, L. B., and Weinberger, D. R. (1988). Cerebral structural pathology in schizophrenia: Evidence for a selective prefrontal cortical defect. Am. J. Psych. 145, 154-163.
57. Siracusa, L. D., Rosner, M. H., Vigano, M. A., Gilbert, D.J., Staudt, L. M., Copeland, N. G., and Jenkins, N. A. (1991). Chromosomal location of the octamer transcription factors, Otf-1, Otf-2, and Otf-3, defines multiple Otf-3-related sequences dispersed in the mouse genome. Genomics 10, 313-326.
58. Sock, E., Enderich, J., Rosenfeld, M. G., and Wegner, M. (1996). Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6. J. Biol. Chem. 271, 17512-17518.
59. Sock, E., Enderich, J., and Wegner, M. (1999). The J domain of papovaviral large tumor antigen is required for synergistic interaction with the POU-domain protein Tst-1/Oct6/SCIP. Mol. Cell Biol. 19, 2455-2464.
60. Spaniol, P., Bornmann, C., Hauptmann, G., and Gerster, T. (1996). Class III POU genes of zebrafish arc predominantly expressed in the central nervous system. Nucleic Acids Res. 24, 4874-4881.
61. Sumiyama, K., Washio-Watanabe, K., Ono, T., Yoshida, M. C., Hayakawa, T., and Ueda, S. (1998). Human class III POU genes, POU3F1 and POU3F3, map to chromosomes 1p34.1 and 3p14.2. Mamm. Genome 9, 180-181.
62. Suzuki, N., Rohdewohld, H., Neuman, T., Gruss, P., and Scholer, H. R. (1990). Oct-6: A POU transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J. 9, 3723-3732.
63. Takeda, J., Seino, S., and Bell, G. I. (1992). Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res. 20, 4613-4620.
64. Thali, M., Muller, M. M., DeLorenzi, M., Matthias, P., and Bienz, M. (1988). Drosophila homoeotic genes encode transcriptional activators similar to mammalian OTF-2. Nature 336, 598-601.
65. Tobler, A., Schreiber, E., and Fontana, A. (1993). The human Oct-6 POU transcription factor lacks the first 50 amino acids of its murine counterpart. Nucleic Acids Res. 21, 1043.
66. Tole, S., and Grove, E. A. (2001). Detailed field pattern is intrinsic to the embryonic mouse hippocampus early in neurogenesis. J. Neurosci. 21, 1580-1589.
67. Ward, K. E., Friedman, L., Wise, A., and Schulz, S. C. (1996). Meta-analysis of brain and cranial size in schizophrenia. Schizophr. Res. 22, 197-213.
68. Wegner, M., Drolet, D. W., and Rosenfeld, M. G. (1993a). POU-domain proteins: Structure and function of developmental regulators. Curr. Opin. Cell Biol. 5, 488-498.
69. Wegner, M., Drolet, D. W., and Rosenfeld, M. G. (1993b). Regulation of JC virus by the POU-domain transcription factor Tst-1. Implications for progressive multifocal leukoencephalopathy. Proc. Natl. Acad. Sci. USA 90, 4743-1747.
70. Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiat. 44, 660-669.
71. Weinstein, D. E., Burrola, P. G., and Lemke, G. (1995). Premature Schwann cell differentiation and hypermyelination in mice expressing a targeted antagonist of the POU transcription factor SCIP. Mol. Cell. Neurosci. 3, 212-229.
72. Wierman, M. E., Xiong, X., Kepa, J. K., Spaulding, A. J., Jacobsen, B. M., Fang, Z., Nilaver, G., and Ojeda, S. R. (1997). Repression of gonadotropin-releasing hormone promoter activity by the POU homeodomain transcription factor SCIP/Oct-6/Tst-1: A regulatory mechanism of phenotype expression? Mol. Cell. Biol. 17, 1652-1665.
73. Wilson, G. L., Najfeld, V., Kozlow, E., Menniger, J., Ward, D., and Kehrl, J. H. (1993). Genomic structure and chromosomal mapping of the human CD22 gene. J. Immunol. 150, 5013-5024.
74. Xia, Y. R., Andersen, B., Mehrabian, M., Diep, A. T., Warden, C. H., Mohandas, T., McEvilly, R. J., Rosenfeld, M. G., and Lusis, A. J. (1993). Chromosomal organization of mammalian POU domain factors. Genomics 18, 126-130.
75. Yang, X., McDonough, J., Fyodorov, D., Morris, M., Wang, F., and Deneris, E. S. (1994). Characterization of an acetylcholine receptor alpha 3 gene promoter and its activation by the POU domain factor SCIP/Tst-1. J. Biol. Chem. 269, 10252-10264.
76. Zorick, T. S., and Lemke, G. (1996). Schwann cell differentiation. Curr. Opin. Cell Biol. 6, 870-876.